Summit Therapeutics, Inc. (SMMT)
21.47
+0.64
(+3.07%)
USD |
NASDAQ |
Apr 30, 16:00
17.88
-3.59
(-16.72%)
After-Hours: 20:00
Summit Therapeutics EPS Diluted (Quarterly) : -0.286 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Revolution Medicines, Inc. | -1.855 |
| BioMarin Pharmaceutical, Inc. | -0.2423 |
| Eli Lilly & Co. | 7.024 |
| Merck & Co., Inc. | 1.191 |
| Soleno Therapeutics, Inc. | 0.7904 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -219.17M |
| Total Expenses (Quarterly) | 219.17M |
| Enterprise Value | 15.46B |
| Earnings Yield | -6.73% |
| Normalized Earnings Yield | -6.729 |